Dysregulated cholesterol regulatory genes in hepatocellular carcinoma

被引:0
|
作者
Dan Cao
Huan Liu
机构
[1] Affiliated Hospital of North Sichuan Medical College,Department of Respiratory and Critical Care Medicine
[2] West China Hospital of Sichuan University,Center of Infectious Diseases
来源
European Journal of Medical Research | / 28卷
关键词
Hepatocellular carcinoma; Cholesterol; Tumorigenesis; Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Cholesterol is an indispensable component in mammalian cells, and cholesterol metabolism performs important roles in various biological activities. In addition to the Warburg effect, dysregulated cholesterol metabolism is one of the metabolic hallmarks of several cancers. It has reported that reprogrammed cholesterol metabolism facilitates carcinogenesis, metastasis, and drug-resistant in various tumors, including hepatocellular carcinoma (HCC). Some literatures have reported that increased cholesterol level leads to lipotoxicity, inflammation, and fibrosis, ultimately promoting the development and progression of HCC. Contrarily, other clinical investigations have demonstrated a link between higher cholesterol level and lower risk of HCC. These incongruent findings suggest that the connection between cholesterol and HCC is much complicated. In this report, we summarize the roles of key cholesterol regulatory genes including cholesterol biosynthesis, uptake, efflux, trafficking and esterification in HCC. In addition, we discuss promising related therapeutic targets for HCC.
引用
收藏
相关论文
共 50 条
  • [1] Dysregulated cholesterol regulatory genes in hepatocellular carcinoma
    Cao, Dan
    Liu, Huan
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [2] Dysregulated cholesterol regulatory genes as a diagnostic biomarker for cancer
    Kuldeep, Seema
    Soni, Sneha
    Srivastava, Anubhav
    Mishra, Anjali
    Sharma, Lokendra Kumar
    Mandal, Chandi C.
    JOURNAL OF GENE MEDICINE, 2023, 25 (04):
  • [3] Identifying hub genes and dysregulated pathways in hepatocellular carcinoma
    Jin, B.
    Wang, W.
    Du, G.
    Huang, G. -Z.
    Han, L. -T.
    Tang, Z. -Y.
    Fan, D. -G.
    Li, J.
    Zhang, S. -Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (04) : 592 - 601
  • [4] Expression of iron regulatory genes in a rat model of hepatocellular carcinoma
    Holmstrom, Petra
    Gafvels, Mats
    Eriksson, Lennart C.
    Dzikaite, Vijole
    Hultcrantz, Rolf
    Eggertsen, Gosta
    Stal, Per
    LIVER INTERNATIONAL, 2006, 26 (08) : 976 - 985
  • [5] Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling
    Liang, Jessie Qiaoyi
    Teoh, Narcissus
    Xu, Lixia
    Pok, Sharon
    Li, Xiangchun
    Chu, Eagle S. H.
    Chiu, Jonathan
    Dong, Ling
    Arfianti, Evi
    Haigh, W. Geoffrey
    Yeh, Matthew M.
    Ioannou, George N.
    Sung, Joseph J. Y.
    Farrell, Geoffrey
    Yu, Jun
    NATURE COMMUNICATIONS, 2018, 9
  • [6] Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling
    Jessie Qiaoyi Liang
    Narcissus Teoh
    Lixia Xu
    Sharon Pok
    Xiangchun Li
    Eagle S. H. Chu
    Jonathan Chiu
    Ling Dong
    Evi Arfianti
    W. Geoffrey Haigh
    Matthew M. Yeh
    George N. Ioannou
    Joseph J. Y. Sung
    Geoffrey Farrell
    Jun Yu
    Nature Communications, 9
  • [7] Dysregulated fatty acid metabolism in hepatocellular carcinoma
    Wang, Mingda
    Han, Jun
    Xing, Hao
    Zhang, Han
    Li, Zhenli
    Liang, Lei
    Li, Chao
    Dai, Shuyang
    Wu, Mengchao
    Shen, Feng
    Yang, Tian
    HEPATIC ONCOLOGY, 2016, 3 (04) : 241 - 251
  • [8] Dysregulated serum metabolites in staging of hepatocellular carcinoma
    Wang, Wenjuan
    Lv, Junxia
    Chen, Nan
    Lou, Bin
    Mao, Weilin
    Wang, Peipei
    Chen, Yu
    CLINICAL BIOCHEMISTRY, 2018, 61 : 7 - 11
  • [9] Identification of personalized dysregulated pathways in hepatocellular carcinoma
    Li, Hong
    Jiang, Xiumei
    Zhu, Shengjie
    Sui, Lihong
    PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (04) : 327 - 332
  • [10] Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma
    Ke, Changwei
    Dai, Shejiao
    Xu, Fangshi
    Yuan, Jia
    Fan, Shuting
    Chen, Yang
    Yang, Longbao
    Li, Yong
    BMC CANCER, 2023, 23 (01)